Amwell to Report First Quarter 2021 Operating Results and Host Conference Call on Wednesday, May 12, 2021

BOSTON–(BUSINESS WIRE)–Amwell®, (NYSE: AMWL) (the “Company”) a national telehealth leader, today announced that it will report first quarter ended March 31, 2021 operating results on Wednesday, May 12, 2021. Following distribution of the earnings release via wire services, the Amwell management team will host a live conference call and webcast at 5:00 p.m. Eastern Time … [Read more…]

HTL Biotechnology and Echelon Biosciences Inc. announce strategic partnership to advance biopolymer platform and hyaluronic acid research tools

SALT LAKE CITY & PARIS–(BUSINESS WIRE)–HTL, the worldwide leader in biotechnology solutions using hyaluronic acid (HA) and other biopolymers, and Echelon Biosciences Inc., a U.S.-based global supplier of biochemical reagents, assays, and services to research and development laboratories, announced today their new distribution and product development partnership. The partnership will enable distribution of high-quality HA … [Read more…]

NantHealth Announces $137.5 Million New Financing With Highbridge Capital Management and Nant Capital

– Transaction proceeds to be used to retire NantHealth’s existing convertible notes due in 2021, invest in established businesses, and accelerate growth initiatives including NantHealth’s continued expansion of SaaS offerings – Maturity date of NantHealth’s existing subordinated note extended to 2026 CULVER CITY, Calif.–(BUSINESS WIRE)–NantHealth, Inc. (NASDAQ-GS: NH), a provider of enterprise solutions that help … [Read more…]

Greenwich LifeSciences Announces Update of GP2 Phase III Clinical Trial Design at the 2021 AACR Annual Meeting

The GP2 Phase III clinical trial design was presented in a poster during the 2021 American Association for Cancer Research (AACR) Annual Meeting, introduced by the Global Principal Investigator, Professor Mothaffar F. Rimawi of Baylor College of Medicine. The Company plans to complete manufacturing of GP2 by the end of the 3rd quarter 2021 and … [Read more…]

CommonTrust Network Expands to Cover 32 Countries, Enabling Trusted Health Data for Global Travel

Six nations of East Africa Community join network now spanning Africa, Asia, Europe, Oceania and the Americas Network includes testing and vaccination providers in 32 countries committed to empowering individuals with verifiable digital health certificates based on open, interoperable standards Testing partners include Labcorp, Quest Diagnostics, Thermo Fisher Scientific, BioReference, Centogene, Cerballiance, Eurofins, Flow Health, … [Read more…]

Novo Nordisk Achieves the Best Place to Work Certification in South Africa for 2021

JOHANNESBURG–(BUSINESS WIRE)–#Novonordisk–Novo Nordisk South Africa, an affiliate of the global healthcare company with more than 90 years of innovation and leadership in diabetes care, has been recently recognized as one of the best places to work in South Africa for 2021. The company received outstanding scores across several aspects of their workplace such as learning … [Read more…]

Deenova Wins First Private Contract in Spain for Hospital Centro de Andalucía de Lucena

MILAN–(BUSINESS WIRE)–Deenova announced today that its unrivalled market momentum unceasingly expands to Spain´s private hospital market, with its first award for won by Deenova in cooperation with Algalasa at Hospital Centro de Andalucía at Lucena, Cordoba, part of the new health enterprise Amaveca Salud. Gaspar G. De Viedma, Vice Chairman of the Deenova Board of … [Read more…]

TILT Biotherapeutics and MSD to Collaborate on Clinical Trial of Adenoviral Cancer Immunotherapeutic TILT-123 in Combination with KEYTRUDA® (pembrolizumab) for Ovarian Cancer

HELSINKI, Finland–(BUSINESS WIRE)–TILT Biotherapeutics, a clinical-stage biotechnology company developing cancer immunotherapeutics, today announced a clinical trial collaboration agreement with MSD, a premier research-intensive biopharmaceutical company, to evaluate TILT’s adenoviral cancer immunotherapy TILT-123, a dual cytokine armed oncolytic adenovirus, in combination with KEYTRUDA® (pembrolizumab), MSD’s anti-PD-1 therapy, in a Phase I dose escalation trial in platinum … [Read more…]

Polyneuron and University of Basel Awarded Grant of CHF 1.2M to Advance Novel Treatments to Support ABO-Incompatible Transplants

BASEL, Switzerland–(BUSINESS WIRE)–Polyneuron Pharmaceuticals AG, a clinical-stage developer of a new class of antigen-specific polymers for the treatment of patients with serious autoimmune diseases, today announced that the company and collaborators at the University of Basel have received a grant from the Swiss Innovation Agency Innosuisse to support a project valued at CHF 1.2 million. … [Read more…]

GenScript Biotech BV and IES Diagnostics Forge Distribution Agreement for SARS-CoV-2 Neutralizing Antibody Kit

Exclusive agreement for region brings GenScript’s innovative cPass™ kit to Spain, Portugal and Andorra LEIDEN, Netherlands & BILBAO, Spain–(BUSINESS WIRE)–GenScript Biotech (Netherlands) BV, a subsidiary of GenScript Biotech Corporation (“GenScript”, Stock Code: 1548.HK), a world-leading biotechnology company, and IES Diagnostics, the Life Science division of IES Medical, a company based in Spain, announced they have … [Read more…]